ANDA 40663, held by Zydus Pharms USA. Warfarin Sodium.
As of Nov 16, 2026, ANDA 40663 (Warfarin Sodium), held by Zydus Pharms USA, was first approved by FDA on May 30, 2006, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 30, 2006 | Original application | Approved | None posted |
| Warfarin Sodium1MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium2MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium2.5MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium3MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium4MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium5MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium6MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium7.5MG · tablet;oral | Warfarin Sodium | Rx |
| Warfarin Sodium10MG · tablet;oral | Warfarin Sodium | Rx |
| Apr 12, 2016 | Supplement 11Labeling · Standard review | Approved | None posted |
| Apr 19, 2012 | Supplement 9Labeling | Approved | None posted |
| Jan 30, 2012 | Supplement 7Labeling | Approved | None posted |
| May 20, 2010 | Supplement 6Labeling | Approved | None posted |
| Dec 17, 2008 | Supplement 5Labeling | Approved | None posted |
| Aug 22, 2008 | Supplement 4Labeling | Approved | None posted |
| Feb 5, 2008 | Supplement 3Labeling | Approved | None posted |
| Jan 10, 2007 | Supplement 1Labeling | Approved | None posted |
| May 30, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters